Akoustis Technologies Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies or view top-rated stocks.

Wall Street analysts have given Akoustis Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akoustis Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, August 23rd 2021.
View our earnings forecast for Akoustis Technologies.

Akoustis Technologies, Inc. (NASDAQ:AKTS) announced its earnings results on Sunday, May, 2nd. The technology company reported ($0.22) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.01. The technology company earned $2.52 million during the quarter, compared to analyst estimates of $2.25 million. Akoustis Technologies had a negative net margin of 913.86% and a negative trailing twelve-month return on equity of 51.94%. The firm's revenue was up 594.2% on a year-over-year basis.
View Akoustis Technologies' earnings history.

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AKTS shares have increased by 70.1% and is now trading at $9.03.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued twelve-month price objectives for Akoustis Technologies' stock. Their forecasts range from $14.00 to $20.00. On average, they anticipate Akoustis Technologies' stock price to reach $17.40 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price.
View analysts' price targets for Akoustis Technologies or view top-rated stocks among Wall Street analysts.

Some companies that are related to Akoustis Technologies include Telkom SA SOC (TLKGY), Plantronics (POLY), ADTRAN (ADTN), AudioCodes (AUDC), NETGEAR (NTGR), Clearfield (CLFD), DZS (DZSI), Exlites Holdings International (EXHI), Sunworks (SUNW), Minim (MINM), Franklin Wireless (FKWL), Zoom Telephonics (ZMTP), Communications Systems (JCS), ClearOne (CLRO) and Altigen Communications (ATGN).
View all of AKTS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Akoustis Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Taylor Frigon Capital Management LLC (0.98%) and SkyOak Wealth LLC (0.12%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies.

AKTS stock was sold by a variety of institutional investors in the last quarter, including Taylor Frigon Capital Management LLC, and SkyOak Wealth LLC. Company insiders that have sold Akoustis Technologies company stock in the last year include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars, and Suzanne B Rudy.
View insider buying and selling activity for Akoustis Technologies or view top insider-selling stocks.

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AKTS stock can currently be purchased for approximately $9.03.

Akoustis Technologies has a market capitalization of $454.88 million and generates $1.79 million in revenue each year. The technology company earns $-36,140,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis.

Akoustis Technologies employs 95 workers across the globe.

The official website for Akoustis Technologies is www.akoustis.com.

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]